Colorectal Tumors

18 registered clinical trials studyying Colorectal Tumors.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutati NCT05358249	Novartis Pharmaceuticals	Phase 1 / Phase 2
Completed	A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors NCT05136092	Weill Medical College of Cornell University	N/A
Terminated	VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC) NCT04166383	National Cancer Institute (NCI)	Phase 2
Completed	Effect of Intravenous Infusion of Lidocaine on Patients Undergoing Radical Resection of Colorectal Tumors NCT05484687	Affiliated Hospital of Nantong University	N/A
Completed	A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorecta NCT03428958	NuCana plc	Phase 1 / Phase 2
Completed	An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab NCT03377361	Bristol-Myers Squibb	Phase 1 / Phase 2
Terminated	Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated NCT03050814	National Cancer Institute (NCI)	Phase 2
Completed	Predictive Factors for Anastomotic Leakage After Colorectal Surgery NCT02347735	Maastricht University Medical Center	—
Completed	Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) NCT01671592	Pawel Kalinski	Phase 1
Completed	Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Popul NCT01793207	Cairo University	—
Terminated	Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer NCT01545141	Roswell Park Cancer Institute	Phase 1 / Phase 2
Completed	ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer NCT01675128	National Cancer Institute (NCI)	Phase 1 / Phase 2
Withdrawn	A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin NCT01157039	AHS Cancer Control Alberta	Phase 2
Completed	Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution & Oncologic Outcome NCT02399059	Hospital General Universitario Elche	Phase 3
Completed	Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorec NCT01139138	The Queen Elizabeth Hospital	Phase 1 / Phase 2
Completed	Dendritic Cell Vaccination for Patients with Solid Tumors NCT01291420	University Hospital, Antwerp	Phase 1 / Phase 2
Completed	Nelfinavir, a Phase I/Phase II Rectal Cancer Study NCT00704600	Maastricht Radiation Oncology	Phase 1 / Phase 2
Completed	A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After NCT00478634	Novartis Pharmaceuticals	Phase 1